Hallett David has filed 4 insider transactions across 1 company since February 2026.
Most recent transaction: a tax payment of 11908 shares of RECURSION PHARMACEUTICALS, INC. ($RXRX) on February 17, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Hallett David | Chief Scientific Officer | F | Class A Common Stock | 11908 | $3.49 | 1,097,151.0000 | 514,895,802 | 1.07% | 0.00% |
| Feb. 6, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Hallett David | Chief Scientific Officer | A | Class A Common Stock | 502064 | $0.00 | 1,096,205.0000 | 514,895,802 | 84.50% | 0.10% |
| Feb. 6, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Hallett David | Chief Scientific Officer | A | Class A Common Stock | 24254 | $0.00 | 1,120,459.0000 | 514,895,802 | 2.21% | 0.00% |
| Feb. 6, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Hallett David | Chief Scientific Officer | F | Class A Common Stock | 11400 | $3.98 | 1,109,059.0000 | 514,895,802 | 1.02% | 0.00% |